106 related articles for article (PubMed ID: 38771996)
1. State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care.
Balmaceda NB; Petrillo A; Krishnan M; Zhao JJ; Kim S; Klute KA; Sundar R
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431060. PubMed ID: 38771996
[TBL] [Abstract][Full Text] [Related]
2. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials.
Huynh J; Patel K; Gong J; Cho M; Malla M; Parikh A; Klempner S
Curr Treat Options Oncol; 2021 Sep; 22(11):100. PubMed ID: 34524553
[TBL] [Abstract][Full Text] [Related]
4. Advances in Immunotherapy in Esophagogastric Cancer.
Jazieh K; Yoon H; Zhu M
Hematol Oncol Clin North Am; 2024 Jun; 38(3):599-616. PubMed ID: 38493074
[TBL] [Abstract][Full Text] [Related]
5. Nivolumab with or without chemotherapy for metastatic gastroesophageal cancers and future perspectives.
Sewastjanow-Silva M; Yamashita K; Rosa Vicentini E; Hirschmann M; Pool Pizzi M; Trail AM; Waters RE; Rogers JE; Ajani JA
Expert Rev Anticancer Ther; 2022 Nov; 22(11):1177-1181. PubMed ID: 36266061
[TBL] [Abstract][Full Text] [Related]
6. The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction.
Valkema MJ; Mostert B; Lagarde SM; Wijnhoven BPL; van Lanschot JJB
Updates Surg; 2023 Feb; 75(2):313-323. PubMed ID: 35836094
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions.
Balmaceda NB; Kim SS
J Gastrointest Cancer; 2024 Mar; 55(1):153-167. PubMed ID: 38127239
[TBL] [Abstract][Full Text] [Related]
8. Top Gastric Cancer Articles from 2022 and 2023 to Inform Your Cancer Practice.
Mullen JT
Ann Surg Oncol; 2024 Jun; 31(6):3978-3983. PubMed ID: 38388931
[TBL] [Abstract][Full Text] [Related]
9. Role of Immunotherapy in Advanced Gastroesophageal Cancer.
Terrero G; Lockhart AC
Curr Oncol Rep; 2020 Aug; 22(11):112. PubMed ID: 32803457
[TBL] [Abstract][Full Text] [Related]
10. Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy.
Nakajima H; Nakatsura T
Immunol Med; 2021 Mar; 44(1):10-15. PubMed ID: 32643578
[TBL] [Abstract][Full Text] [Related]
11. The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials.
Saeed A; Park R; Sun W
J Hematol Oncol; 2021 Jan; 14(1):13. PubMed ID: 33436042
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
13. Dawn of precision medicine on gastric cancer.
Ishii T; Kawazoe A; Shitara K
Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
[TBL] [Abstract][Full Text] [Related]
14. Harnessing biomarkers of response to improve therapy selection in esophago-gastric adenocarcinoma.
Fong CY; Chau I
Pharmacogenomics; 2021 Jul; 22(11):703-726. PubMed ID: 34120461
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell Carcinoma.
Qureshi HA; Lee SM
Curr Treat Options Oncol; 2019 Mar; 20(4):31. PubMed ID: 30874960
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in PD-1/PD-L1 blockade research for gastroesophageal malignancies.
Chen M; Li C; Sun M; Li Y; Sun X
Front Immunol; 2022; 13():1043517. PubMed ID: 36505480
[TBL] [Abstract][Full Text] [Related]
17. Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectives.
Takahari D; Nakayama I
Int J Clin Oncol; 2023 Nov; 28(11):1431-1441. PubMed ID: 37500970
[TBL] [Abstract][Full Text] [Related]
18. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
19. The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.
Murphy AG; Kelly RJ
Hematol Oncol Clin North Am; 2017 Jun; 31(3):485-498. PubMed ID: 28501089
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in Cervical Cancer.
Mauricio D; Zeybek B; Tymon-Rosario J; Harold J; Santin AD
Curr Oncol Rep; 2021 Apr; 23(6):61. PubMed ID: 33852056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
